Indian Emulsifiers Ltd. · NSE:IEML
Indian Emulsifiers — H2 FY2026 Earnings Presentation
38 slides from Indian Emulsifiers's earnings presentation, Jun 1, 2026
Slide 1: Submission of Investor Presentation to NSE
June 01, 2026 To, The Manager, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Symbol: IEML ISIN: INE0RRU01016 Subject: Submission of Investor Presentation to be made to the Analysts/Investors Dear Sir/ Ma’am Pursuant to
Slide 2: Indian Emulsifiers Ltd. Investor Presentation
INDIAN EMULSIFIERS LTD. INVESTOR PRESENTATION
Slide 3: Company Overview
COMPANY OVERVIEW IE
Slide 4: Indian Emulsifiers Limited
Indian Emulsifiers Limited Founded in 2020, under the name “Indian Emulsifier Private Limited.” One of the major manufacturers of Esters, Esterquats, Polyamides, Polymerized surfactants, Sulphates, Amphoterics, Phosphate esters, Imidazolines, Wax emulsions, Specialty emulsifiers and Formulated produ
Slide 5: Emulsification for Improved Functionality & Customer Value
Emulsification for Improved Functionality & Customer Value Emulsification is the process of blending two liquids that normally don’t mix—like oil and water—into a stable mixture using specialized agents. This is done using emulsifying agents, which help the liquids mix and stay blended by preventing
Slide 6: Management Commentary
Management Commentary FY26 was a year of strong growth despite a challenging global operating environment. Revenue increased 57.93% year- on-year to ₹159.87 crore, while EBITDA grew 24.22% to ₹26.15 crore and profit after tax rose 21.83% to ₹16.20 crore. This performance reflects the resilience of o
Slide 7: Management Commentary
Management Commentary Since April 2026, supply conditions have normalized and cost increases have been passed through to customers. We therefore expect inventory efficiency to improve as volumes continue to grow and supply chain processes are optimized. Creditor days improved significantly as procur
Slide 8: Vision & Mission
Vision & Mission To be a pioneer in specialty chemicals To deliver high-performance specialty chemical manufacturing, with a strong focus on solutions that enhance functionality, delivering tailor-made solutions that address sustainability, and customer value across the diverse needs of its customer
Slide 9: IEL Core Values
IEL Core Values Ideology Innovation To be a pioneer and leading Innovating is key to industry manufacturer in the specialty success, leveraging in-house chemicals industry, delivering R&D and global technology superior service with integrity, alliances to deliver cutting-edge ethics, and pride solut
Slide 10: Key Facts & Figures (Consolidated)
Key Facts & Figures (Consolidated) 30+ 12,000 MTPA Global Presence Portfolio of over 125+ Years of average team specialty chemicals Production Capacity across 9 Countries experience. FY26 FY25 Total Revenue 160.19 Cr Total Revenue 102.66 Cr EBITDA 26.22 Cr EBITDA 21.05 Cr PAT 16.26 Cr PAT 13.30 Cr I
Slide 11: Business Overview
BUSINESS OVERVIEW IE
Slide 12: Products Portfolio & Its Industrial Applications
Products Portfolio & It’s Industrial Applications Ester Amphoterics Formulated by reacting select Favoured in industrial fatty acids, such as oleic or cleaners for its hydrotropic stearic acid, with alcohol and dirt-lifting capabilities. Imidazolines Phosphate Esters Produced via fatty acid– Produce
Slide 13: Serving Key Industrial Verticals
Serving Key Industrial Verticals Ester Amphoterics Fragrances & Flavors: Esters enhance scent Personal Care: Amphoterics offer mildness and and taste in perfumes, cosmetics, and food. skin/hair compatibility in cosmetics. Solvents: Essential in paints, coatings, and Cleaning & Detergents: Provide fo
Slide 14: Building a Competitive Moat
Building a Competitive Moat Experienced Promoter & Competitive Pricing Management Team Diverse Product Portfolio Delivers strong customer value by Led by a proven Promoter and experienced Wide portfolio of over 125 specialty maintaining high product quality and management team, the company leverages
Slide 15: Manufacturing Facility
Manufacturing Facility Location: MIDC Lote Parshuram, 225 km from Mumbai, Ratnagiri District, Maharashtra Strategic Advantage: Close proximity to ports ensures logistical efficiency Capacity Expansion: Increased from 2,400 MT to 12,000 MT per annum with additional reactors Infrastructure: • Advanced
Slide 16: Strategic Initiatives
Strategic Initiatives Increasing Operational Efficiency: Expanding existing manufacturing Ongoing investments in operational capacities to capitalize on industry efficiency and technical capabilities aim to opportunities: boost production, enhance margins, and Continues to scale manufacturing capabi
Slide 17: Southern Emulsifiers: Foray into Australia's Mining Explosives Market
Southern Emulsifiers: Foray into Australia’s Mining Explosives Market Significance of Strategic Entry into the Australian Mining Explosives Market • Market Entry & Expansion: Establish a direct footprint in Australia's high-potential mining emulsifier market. • Customer Proximity: Serve major mining
Slide 18: Financial Outlook: Southern Emulsifiers
Financial Outlook: Southern Emulsifiers Australian subsidiary is expected to generate approximately INR 75 Crores in revenue over the next three years, marking a significant step in our international growth strategy Key Growth Drivers: • Ability to offer customized emulsifier solutions tailored to c
Slide 19: Polaris Specialty Chemicals Inc. Strategic Entry into the U.S. Market
Polaris S pe cialty C he mica ls Inc. Strategic Entry into the U.S. Market Operational Model: Polaris serves as the U.S. distribution arm—handling customs clearance, localized inventory in tanks & totes, and direct last-mile delivery to customer sites. Key Industries Served: Oil & Gas Food Water Tex
Slide 20: Spartan Professional Products: Moving Up the Value Chain
S parta n Prof ess ional P roducts Moving Up the Value Chain ❑ Strategic Transition: Wholly owned subsidiary of IEML, Spartan represents the company’s shift from Dual Business Model a raw material supplier to a finished formulations manufacturer. White Label Manufacturing ❑ Core Objective: Entering
Slide 21: Spartan Professional Products: Moving Up the Value Chain
S parta n Prof ess ional P roducts Moving Up the Value Chain $25–30 Bn Strategic Positioning: Personal Care ➢ Flexible Manufacturing: Serving niche and D2C brands seeking Market Size high-quality, small-batch production. ➢ Segment Targeting: Addressing the underserved mid-premium $11–12 Bn segment t
Slide 22: Industry Overview
INDUSTRY OVERVIEW IE
Slide 23: Global Industry Trends: Chemicals & Specialties
Global Industry Trends: Chemicals & Specialties Global Chemical Industry In USD Trillions • The global chemical Markets which is currently at $5.61 trillion currently is estimated to reach $8.58 trillion by 2029 at a CAGR of 8.6%. 8.58 • The growth in the forecast period can be attributed to stringe
Slide 24: Indian Chemical Market Outlook
Indian Chemical Market Outlook India’s Chemical Industry • India’s chemical industry is valued at $245 billion in 2026 and is anticipated to In USD Billions contribute $383 billion to India’s GDP by 2030. • Increase is expected due to the rise in demand in the end-user segments for specialty chemica
Slide 25: Key Growth Drivers
Key Growth Drivers Rapid Urbanization Technological Advantage Export Growth India's rapid industrialization in sectors Technological advancements are driving Indian specialty chemical manufacturers like agriculture, pharmaceuticals, and innovation in specialty chemicals, enabling have a strong oppor
Slide 26: India's Specialty Chemicals Market Outlook
India’s Specialty Chemicals Market Outlook Specialty Chemicals: India’s Specialty Chemical Industry • The India specialty & fine chemicals market size reached approximately USD 24 Billion in 2026. In USD Billions • The market is estimated to reach USD 35.41 Billion by 2033, exhibiting a growth rate
Slide 27: Management Overview
_ MANAGEMENT OVERVIEW IE
Slide 28: Management Overview
Management Overview Mr. Yash Tikekar Mrs. Vaishali Dipen Tarsariya Mr. Rajaram Gordhanlal Agarwal Managing Director Independent Director Independent Director An Economics graduate with a Master’s in business Completed Masters in Commerce degree from the Professional post graduate with a Institute of
Slide 29: Way Forward
WAY FORWARD IE
Slide 30: Cross Industry Market Opportunities
Cross Industry Market Opportunities Pharmaceutical Formulation Additives Global pharma market is anticipated to reach USD 16.62 by 2031 Billion at a CAGR of 8–15% Opportunity for the Company : Potential for esters, phosphate esters, and wax emulsions as they are used in formulation stabilizers, exci
Slide 31: Future Outlook
Future Outlook Evaluating Inorganic Growth Diversified Industrial Expansion: Opportunities: Evaluating synergistic Targeting industrial segments to acquisitions in India and abroad to unlock growth opportunities over the enhance product portfolio, next 3 years. technologies, and market access—key to
Slide 32: Financial Overview
FINANCIAL OVERVIEW IE
Slide 33: Key Financial Metrics
Key Financial Metrics Total Income EBITDA & EBITDA Margin PAT & PAT Margin 13.23% 12.96% 180 30 22.23% 25.00% 18 10.15% 14% 160.19 20.50% 16.37% 160 19.10% 16 12% 25 20.00% 14 9.46% 140 10% 20 12 120 102.66 15.00% 8% 10 100 15 8 6% 10.00% 80 66.71 10 6 4% 60 5.00% 4 41.18 5 2% 40 2 - 0.00% - 0% 20 F
Slide 34: H2FY26 Consolidated Financial Performance
H2FY26 Consolidated Financial Performance Particulars (In INR Crs) H2FY26 H2FY25 %Chg FY26 FY25 %Chg Net Sales 82.84 49.73 159.82 101.23 Other Income 0.11 0.27 0.36 1.43 Total Income 82.96 50.00 65.9% 160.19 102.66 56.0% Raw Material 65.12 37.80 121.92 71.87 Employee Benefit Expenses 0.24 0.42 1.82
Slide 35: Historical Financial Performance- Consolidated
Historical Financial Performance- Consolidated Particulars (In INR Cr) FY24 FY25 FY26 Revenues 66.68 101.23 159.82 Other Income 0.04 1.43 0.36 Total Income 66.71 102.66 160.19 Raw Material Expenses 47.29 71.87 121.92 Employee Benefits Expense 0.72 1.24 1.82 Other Expenses 3.87 8.50 10.22 Total Expen
Slide 36: Consolidated Balance Sheet
Consolidated Balance Sheet Equities & Liabilities INR Cr) FY24 FY25 FY26 Assets FY24 FY25 FY26 Equity 9.01 12.22 18.33 Non Current Assets Reserves and Surplus 19.43 69.81 128.72 Fixed Assets 19.97 40.37 75.73 Net Worth 28.44 82.03 147.05 Deferred Tax Assets - - - Non Current Liabilities Other Non Cu
Slide 37: Stock Data
STOCK DATA As on 30-04-2026 Price Data (As of 30th Apr 2026) Shareholding Pattern Share Price ₹ 78 Market Capitalization ₹ Cr 143 Promoter & Promoter Group 32.64 No. of Share Outstanding 1.83 Public Face Value ₹ 10.00 FII 62.08 DII 52 Week High ₹ 174 52 Week Low ₹ 58.4 Share Performance for the peri
Slide 38: Thank You
THANK YOU Indian Emulsifiers Limited Confideleap Partners Registered Office: 107, Sumer Kendra, 103-8, Lodha Eternis, MIDC, Behind Mahindra Tower, Andheri East, Mumbai 400093 Pandurang Budhkar Marg, Worli, Mumbai - Maharashtra, India. 400018 Phone: +91 85911 45959 Factory: E-10 Lote Parashuram Indus